Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-79.34M
↓ 74% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-45.61M
Historical baseline
PeriodValueYoY Change
TTM$-79.34M-42.5%
2024$-55.67M-9.8%
2023$-50.69M+11.3%
2022$-57.13M-235.5%
2021$-17.03M-23.2%
2020$-13.82M-